載入...
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study
INTRODUCTION: A still not well defined proportion of patients with multiple myeloma (MM) and eligible for autologous stem cell transplantation (AuSCT) fails to mobilize CD34+ peripheral blood stem cells (PBSC) at all or to collect an adequate number for a safe procedure or sufficient for multiple tr...
Na minha lista:
發表在: | Stem Cell Res Ther |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425876/ https://ncbi.nlm.nih.gov/pubmed/25889496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0033-1 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|